BioSpace News Archive

Hypercholesterolemia Market Upcoming Industry Demand and Future Growth Explored in Latest Research Report By 2030

Forecast to 2030,’ thoroughly examines the Hypercholesterolemia industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Hematuria Treatment Market – Detailed Analysis of Potential Growth, Emerging Trends and Forecasts Report till 2030

Forecast to 2030,’ thoroughly examines the Hematuria Treatment industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Bowel Obstruction Market: Detailed Analysis of Current and Future Industry Data till 2030 With Major Key Players of Industry

Forecast to 2030,’ thoroughly examines the Bowel Obstruction industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Angioedema Market Growth and Key Business Strategies By Leading Industry Players By 2030

Forecast to 2030,’ thoroughly examines the Angioedema industry to provide essential data & information for the targeted readers.

July 29, 2022
·
6 min read
Pharm Country

Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.

Dr. Reddy’s Laboratories Ltd. today announced that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC (“Slayback”), to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic Solution 0.025%, the private label equivalent of Lumify® in U.S. Lumify® is an over-the-counter (OTC) eyedrop that can be used to relieve redness of the eye due to minor eye irritations.

July 29, 2022
·
4 min read